One Platform. Infinite Diagnostic Insights.

Ricovr’s proprietary Plasmonic Fiber-Optic Absorbance Biosensor (P-FAB) is a portable, ultra-sensitive detection engine designed to identify any analyte—from drugs to hormones – with a single, non-invasive saliva sample.

The Mechanism

Ricovr’s P-FAB platform uses a U-bent optical fiber to amplify the interaction between light and target biomarkers at the sensor surface. As light travels through the bend, it creates an evanescent field that is highly sensitive to molecular binding events. This enables rapid, direct detection from saliva without the complexity of traditional laboratory workflows.

Sensitivity at Scale

P-FAB is designed to bring high-sensitivity biomarker detection out of the lab and into real-world testing environments. By combining advanced fiber-optic sensing with a portable reader and disposable cartridge format, Ricovr can deliver precise, digital results at the point of need.

The U-bent fiber increases the surface interaction between light and the sample, allowing subtle biomarker binding events to be detected with high sensitivity.
The platform is engineered to detect extremely low concentrations of target analytes, supporting applications where sensitivity is critical.

Ricovr’s approach reduces the need for complex wash steps, helping simplify the testing workflow and making the technology better suited for point-of-care use.

Capability Traditional Lab Test Traditional Field Tests RICOVR P-FAB
Saliva-based collection Limited Yes Yes
Portable point-of-care format No Yes Yes
High-sensitivity detection Yes Limited Yes
Digital result interpretation Yes Limited Yes
Minimal workflow complexity No Yes Yes
Scalable multi-analyte platform Limited Limited Yes

Validated Performance:


The THC Proof Point

Ricovr’s first application, XALIVA™ THC, demonstrates the power of the P-FAB platform in one of the most challenging and urgent testing categories: recent cannabis use detection. As cannabis legalization expands, employers and safety-sensitive organizations need a better way to make timely, fair, and objective decisions.

The Lead Application

XALIVA™ THC – A rapid saliva-based test designed to detect recent THC use at the point of need, helping organizations modernize workplace and public safety testing.

The Validation

In external validation performed at Rutgers University, Ricovr’s P-FAB technology demonstrated 100% accuracy compared with gold-standard mass spectrometry for detecting THC in human saliva.

The Utility

XALIVA™ THC is designed to address the central problem in cannabis testing: distinguishing recent use from historical exposure. By using saliva, the platform supports more relevant, real-time decision-making for workplace safety, roadside testing, and other safety-sensitive environments.

Point-of-Testing Reality:


The Workflow

Collect a Saliva
Sample

A quick, non-invasive swab eliminates the need for restrooms, special facilities, or gender-specific collection protocols.

Insert Into the
XALIVA Device

The sample cartridge is inserted into the portable reader, enabling on-site analysis with minimal training.

Results in
Minutes

Actionable digital results are available rapidly, reducing reliance on lab turnaround times and helping organizations make timely safety decisions.

Future-Proofing:

The Multi-Analyte Pipeline

Ricovr’s platform is designed as a scalable diagnostic engine, not a single-test product. The same core P-FAB technology can be adapted across multiple analytes and use cases by changing the assay chemistry and cartridge design.

Modular Expansion

A single portable reader can support a pipeline of cartridge-based tests, allowing Ricovr to expand from THC into broader drug panels, clinical biomarkers, women’s health, and infectious disease applications.

Pipeline Verticals

  1. Workplace & Safety:Expanded drug panels for safety-sensitive environments, including opioids, amphetamines, and other high-priority substances.
  2. Clinical Diagnostics:
Rapid biomarker testing for conditions where timely, accessible results can improve decision-making.
  3. Women’s Health:Non-invasive testing opportunities in preeclampsia, hormone monitoring, and reproductive health.
  4. Public Health:Point-of-care screening applications for infectious disease and community health settings.

Awards & Global Recognition

A single portable reader can support a pipeline of cartridge-based tests, allowing Ricovr to expand from THC into broader drug panels, clinical biomarkers, women’s health, and infectious disease applications.

Make Real-Time
Safety Decisions

Modernize workplace testing with a rapid, saliva-based platform designed for accuracy, fairness, and operational efficiency.